Skip to content

An educational intervention to understand Attitudes and address Barriers to Care in Age-related Macular Degeneration: A randomised controlled trial

An educational intervention to understand Attitudes and address Barriers to Care in Age-related Macular Degeneration: A randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000984796
Acronym
The ABCs of AMD
Enrollment
3
Registered
2022-07-13
Start date
2022-05-02
Completion date
2023-06-01
Last updated
2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The research study aims to understand if patients' attitudes towards appropriate care for their Age-related Macular Degeneration can be altered based on the type of education they receive. Two different approaches to providing patient education will be provided. This study will help us understand what type of education helps patients accept care that is best for them. If one approach to education is found to be better, we will share our educational approach with other eye health professionals so that they can help their patients make better care decisions too.

Interventions

Patient-determined education has content designed by patients and clinicians: Attending clinician will deliver Patient-determined Education package during routine baseline clinical eye exam: - Will involve 5 to 10 minutes of face-to-face education on stage of disease diagnosed at this visit plus relevant treatments appropriate to stage (Ex. smoking cessation, use of Amsler Grid, use of eye health supplements or eye injections). Conversations guided primarily by patient questions and interest. -

Patient-determined education has content designed by patients and clinicians: Attending clinician will deliver Patient-determined Education package during routine baseline clinical eye exam: - Will involve 5 to 10 minutes of face-to-face education on stage of disease diagnosed at this visit plus relevant treatments appropriate to stage (Ex. smoking cessation, use of Amsler Grid, use of eye health supplements or eye injections). Conversations guided primarily by patient questions and interest. - May involve material to take-home to read. Material (one page brochure) depends on stage of disease diagnosed at this visit plus relevant treatments appropriate to stage (Ex. smoking cessation, use of Amsler Grid, use of eye health supplements or eye injections) based on most recent published evidence. Take home material offered determined by patient interest and questions. - May be supported by follow-up text message reminders monthly for 6 months post-enrolment. Reminders will focus on treatments relevant to stage of disease diagnosed and may address smoking cessation, use of Amsler Grid, use of eye health supplements or eye injections. Text reminders enrolled determined by patient questions and interests.

Sponsors

University of New South Wales
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults (age greater than 50) diagnosed at the Centre for Eye Health between with: • Large drusen at the macula in either eye, • Pigmentary abnormalities associated with at least medium sized drusen in either eye, • Late AMD (geographic atrophy) • Late AMD (macular neovascularization)

Exclusion criteria

Potential participants must be able to communicate effectively in English and be legally capable to provide formal written direct consent to participate. Potential participants intending to move outside of the study catchment area (NSW) over the duration of study conduct will not be eligible. Patients with other co-morbid ocular disease (Ex. glaucoma) requiring treatment will also not be eligible to participate.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026